Drug
Pti 125
Pti 125: highest development phase Phase 2, developed by United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| PTI-125, 100 mg tablets NCT03748706 | Phase 2 | Alzheimer Disease |
| 50 mg PTI-125 NCT03784300 | Phase 1 | Alzheimer Disease, Early Onset |
Latest
No recent events.
Follow Pti 125 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.